Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Vitamin D mediates crosstalk between COVID-19 and osteoporosis

Vitamin D mediates crosstalk between COVID-19 and osteoporosis

30 Aug 2022
What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

30 Aug 2022
SARS-CoV-2 Omicron BA.2.75 replicates more efficiently than BA.2 or BA.5 sub-variants

SARS-CoV-2 Omicron BA.2.75 replicates more efficiently than BA.2 or BA.5 sub-variants

30 Aug 2022
Study explores differences in the efficiency of COVID-19 vaccine boosters

Study explores differences in the efficiency of COVID-19 vaccine boosters

30 Aug 2022
COVID-19 may provoke IgA-associated vasculitis

COVID-19 may provoke IgA-associated vasculitis

30 Aug 2022
Understanding recombination rates in RNA viruses

Understanding recombination rates in RNA viruses

30 Aug 2022
Researchers review sexual well-being during the SARS-CoV-2 pandemic

Researchers review sexual well-being during the SARS-CoV-2 pandemic

30 Aug 2022
Relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir treatment

Relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir treatment

30 Aug 2022
Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

30 Aug 2022
Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

30 Aug 2022
The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

30 Aug 2022
Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

30 Aug 2022
Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

30 Aug 2022
Risk factors among pregnant and postpartum women with COVID-19

Risk factors among pregnant and postpartum women with COVID-19

30 Aug 2022
Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

30 Aug 2022
mRNA COVID boosters are effective against severe Omicron for at least six months

mRNA COVID boosters are effective against severe Omicron for at least six months

30 Aug 2022
Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

29 Aug 2022
The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

29 Aug 2022
Protection against SARS-CoV-2 reinfections in the Qatari population

Protection against SARS-CoV-2 reinfections in the Qatari population

29 Aug 2022
The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

29 Aug 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback